Breast cancer survivorship in an Asian specialist centre from Malaysia: A retrospective analysis

Authors

  • Azura Rozila Ahmad Consultant Medical Oncologist, Clinical Research Department, Beacon Hospital , Petaling Jaya, 46050 Selangor, Malaysia.
  • Jia Shin Jessica Tan Clinical Informatics Specialist, Clinical Research Department, Beacon Hospital , Petaling Jaya, 46050 Selangor, Malaysia. https://orcid.org/0000-0002-0396-7538
  • Arkonam Balasubramaniam Manivannan Consultant Clinical Oncologist, Department of Oncology; Clinical Research Department, Beacon Hospital , Petaling Jaya, 46050 Selangor, Malaysia.
  • Mohamed Ibrahim Abdul Wahid Consultant Clinical Oncologist, Department of Oncology; Clinical Research Department, Beacon Hospital , Petaling Jaya, 46050 Selangor, Malaysia.

DOI:

https://doi.org/10.3126/ajms.v10i6.25885

Keywords:

Breast cancer, Survival outcome, real world data, Malaysia, Triple Negative Breat Cancer, 5- year survival of Breast Cancer

Abstract

Background: Real world data (RWD) is increasingly relevant in breast cancer (BCa) as it is the most frequently diagnosed cancer. Developed world has seen improved breast cancer survival, however, RWDon BCa survival in Malaysia is still lacking.

Aims and Objectives: This study aims to determine characteristics and survival of BCa patients from a single institute.

Materials and Methods: Retrospective analysis of 168 BCa patients who were treated with at least one treatment modality in Beacon International Specialist Centre (BISC) from 2008-2012 was conducted. Patient characteristicsand treatments received were analysed descriptively to survival outcome.Vital status was obtained from the National Registry of Birth and Death (NRD) records. Observed survival rates wereestimated by Kaplan-Meier method and difference between groups by log-rank.

Results: Of 143 eligible BCa patients,28 (19.6%) died during the study period. Five-year BCa specific survival rates were 100% for Stage I and II, 79.31% for stage III and 38.89% for Stage IV disease. In the multivariate analysis, higher stage at diagnosis, triple negative breast cancer with metastases and higher grade were associated with worse survival outcomes. The overall 5-year survival rate of BCa patients in BISC from 2008-2012 compares favourably to the survival data of developed countries.

Conclusion: In conclusion, the overall 5-year survival rate of BCa patients in BISC compares favourably to the survival data of developed countries, as well as to other institutions.

Downloads

Download data is not yet available.
Abstract
679
PDF
583

Downloads

Published

2019-10-30

How to Cite

Ahmad, A. R., Tan, J. S. J., Manivannan, A. B., & Wahid, M. I. A. (2019). Breast cancer survivorship in an Asian specialist centre from Malaysia: A retrospective analysis. Asian Journal of Medical Sciences, 10(6), 22–27. https://doi.org/10.3126/ajms.v10i6.25885

Issue

Vol. 10 No. 6 (2019)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).